Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |